Kinfo
Balchem Corporation logo

Balchem Corporation

BCPCNASDAQBasic Materials·US · USD
$162.15
-1.38 (-0.84%)
Prices as of July 10, 2026 · market closed

Price

Key statistics

Valuation
Market cap5.21B USD
Enterprise value5.32B USD
Trailing P/E33.23
Forward P/E26.54
PEG ratio3.21
Price / sales4.93
Price / book4.05
Profitability
Gross margin37.34%
Operating margin20.88%
Profit margin14.95%
Return on assets8.09%
Return on equity12.68%
Income (TTM)
Revenue1.06B USD
Gross profit383.55M USD
EBITDA260.29M USD
Net income158.08M USD
Diluted EPS$4.88
Rev. growth (YoY)8.10%
Balance sheet
Total cash72.87M USD
Total debt184.71M USD
Debt / equity14.37
Current ratio2.55
Book value / share$40.00
Cash flow (TTM)
Operating cash flow220.16M USD
Levered free cash flow138.14M USD
Shares & price
Shares outstanding32.13M
Float31.95M
Held by institutions92.19%
Beta0.81
50-day MA$162.94
200-day MA$162.47
52-week high$183.90
52-week low$139.17
Dividends
Forward rate
$3.84
Yield
2.37%
Payout ratio
19.71%
Frequency
Annual
Recent payments
  • 2025-12-23$0.96
Earnings (EPS)
DateEst.ActualSurprise2026-06-25-0.14-0.16−14.29%2026-05-202.913.09+6.19%2026-04-301.331.33+0.00%2026-02-201.291.31+1.55%
About Balchem Corporation

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for diverse industries worldwide. Operating through three key segments, it leads in Human Nutrition and Health, providing human-grade choline nutrients, mineral amino acid chelated products, and ingredients for food, beverage, pharmaceutical, and health applications. The Animal Nutrition and Health segment delivers nutritional solutions derived from microencapsulation and chelation technologies, including essential nutrient choline chloride for animal feed. The Specialty Products segment focuses on repackaging and distributing performance gases and chemicals for medical device sterilization, plant nutrition, and industrial uses. Balchem Corporation serves nutritional, food, pharmaceutical, animal health, and industrial markets, emphasizing innovative solutions that enhance health and performance. Founded in 1967 and headquartered in New Jersey, it plays a vital role in the specialty chemicals sector by supplying high-quality, technology-driven ingredients to support global health, nutrition, and industrial needs.

Sector
Basic Materials
Industry
Specialty Chemicals
CEO
Mr. Theodore Lee Harris
Employees
1,368
Headquarters
Montvale, NJ, United States

Frequently asked questions about Balchem Corporation